tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
US Market
CRDF
Cardiff Oncology
RESEARCH TOOLSreports

Cardiff Oncology (CRDF) Financial Statements

1,981 Followers

Cardiff Oncology Financial Overview

Cardiff Oncology's market cap is currently $108.02M. The company's EPS TTM is $-0.11; its P/E ratio is -4.09; Cardiff Oncology is scheduled to report earnings on February 24, 2026, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 593.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Gross Profit$ -311.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Operating Income$ -48.96M$ -48.65M$ -45.41M$ -39.90M$ -28.86M
EBITDA$ -44.97M$ -48.25M$ -45.01M$ -39.67M$ -28.40M
Net Income$ -45.88M$ -45.43M$ -41.44M$ -38.70M$ -28.29M
Balance Sheet
Cash & Short-Term Investments$ 58.30M$ 91.75M$ 74.82M$ 105.27M$ 140.82M
Total Assets$ 61.88M$ 97.19M$ 81.64M$ 116.19M$ 149.54M
Total Debt$ 832.00K$ 1.52M$ 2.15M$ 2.71M$ 3.12M
Net Debt$ -16.64M$ -49.95M$ -19.51M$ -13.63M$ -8.82M
Total Liabilities$ 16.50M$ 14.24M$ 11.90M$ 9.85M$ 9.13M
Stockholders' Equity$ 45.39M$ 82.95M$ 69.74M$ 106.34M$ 140.42M
Cash Flow
Free Cash Flow$ -37.97M$ -37.77M$ -31.47M$ -34.71M$ -23.25M
Operating Cash Flow$ -37.92M$ -37.69M$ -30.89M$ -33.82M$ -23.04M
Investing Cash Flow$ 1.34M$ 13.73M$ 36.20M$ 38.15M$ -131.45M
Financing Cash Flow$ 2.58M$ 53.78M$ 0.00$ 75.00K$ 35.45M
Currency in USD

Cardiff Oncology Earnings and Revenue History

Income Statement >

Cardiff Oncology Debt to Assets

Balance Sheet >

Cardiff Oncology Cash Flow

Cash Flow >

Cardiff Oncology Forecast EPS vs Actual EPS

Earnings >